-
<![CDATA[Lymphoma Survivors Find Fatigue Relief From Multidisciplinary Intervention]]>
18 Oct 2025 19:00 GMT
… the REFUEL trial were lymphoma survivors who were two … oxygen uptake and diet in lymphoma survivors with chronic fatigue, … non-Hodgkin lymphoma and 52% had Hodgkin lymphoma. The majority … intervention on fatigue in lymphoma survivors with chronic fatigue- …
-
<![CDATA[Outlining Considerations for the Rare Lymphoma Treatment Paradigm]]>
17 Oct 2025 21:13 GMT
… University, about these rarer lymphoma variants. Specifically, identifying and … guarantee.
Funding for Rare Lymphomas: Sustaining Research Through Uncertainty … /3f4rwrzu
Lymphoma Research Foundation. About Lymphoma and Lymphoma Subtypes. Accessed …
-
<![CDATA[Discussing the Risk of Secondary Cancers From CAR T Therapy in Patients With B-Cell Lymphoma ]]>
17 Oct 2025 17:33 GMT
… about T-cell leukemias and lymphomas in CAR T patients, emphasizing … risk-benefit perspective. The primary lymphoma represents an immediate, life-threatening … mutagenesis causation.
Many T-cell lymphomas in CAR-positive patients carry …
-
<![CDATA[Transitioning Patients Back to the Community Setting After CAR T Therapy for B-Cell Lymphoma]]>
17 Oct 2025 17:33 GMT
Lynch describes the individualized approach to determining community transition timing, now flexible between 14 and 30 days post infusion following REMS dissolution. Decisions depend on ongoing toxicities and community team comfort levels. Hematologic …
-
Lower-Dose RT Effective in Aggressive Lymphomas
17 Oct 2025 07:57 GMT
… with diffuse large B-cell lymphoma (DLBCL) and high-grade B … -cell lymphoma (HGBL) who achieved a complete … Results
The phase 2 International Lymphoma Radiation Oncology Group study enrolled …
-
<![CDATA[Dr Wang on the Role of Bridging Radiotherapy Prior to CAR T-Cell Therapy in B-Cell Lymphoma]]>
17 Oct 2025 03:40 GMT
… of patients with B-cell lymphomas.
CAR T-cell therapy has … relapsed/refractory B-cell lymphoma, Wang began. The approach has … relapsed/refractory B-cell lymphomas. The study included 26 patients …
-
<![CDATA[Immunotherapy EO2463 Receives FDA Fast Track for Follicular Lymphoma]]>
16 Oct 2025 23:38 GMT
… the Unmet Need in Follicular Lymphoma?
Follicular lymphoma, an indolent subtype of … Fast Track designation in follicular lymphoma for lead OncoMimics™ immunotherapy EO2463 … Patients With Indolent Non-Hodgkin Lymphoma (SIDNEY). ClinicalTrials.gov. Updated …
-
Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight
16 Oct 2025 22:04 GMT
… options, visit @ Approved Indolent Lymphoma Drugs
Indolent Lymphoma Competitive Landscape
Several potential … Squibb, among others.
Follicular Lymphoma Market
Follicular Lymphoma Market Insights, Epidemiology, and …
-
New Combination Therapy Shows Promise for Aggressive Lymphoma Resistant to Immunotherapy
16 Oct 2025 21:33 GMT
… natural killer/T-cell lymphoma (R/R NKTL), a … rare subtype of non-Hodgkin lymphoma that currently has no standard … and principal investigator in the Lymphoma Translational Research Laboratory at the …
-
<![CDATA[FDA Grants FTD to Novel Cancer Vaccine in Low Tumor Burden Follicular Lymphoma]]>
16 Oct 2025 19:08 GMT
… patients with newly diagnosed follicular lymphoma, with 15% achieving complete … with newly diagnosed asymptomatic follicular lymphoma results in monotherapy objective clinical … patients with indolent non-Hodgkin lymphoma (SIDNEY). ClinicalTrials.gov. Updated …
About
© 1995-2025